Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Japan”
- Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's LymphomaActive Not Recruiting
Sponsor: AbbVie
Non-Hodgkin's Lymphoma
United States, Australia, Israel, Japan, United Kingdom
Sponsor: Takeda
Immune Thrombocytopenic Purpura (ITP)
United States, Australia, Bulgaria, China, Croatia +10 more
- A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of ProgressionActive Not Recruiting
Sponsor: Hoffmann-La Roche
Primary IgA Nephropathy
United States, Argentina, Australia, Brazil, Canada +16 more
- Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21)Active Not Recruiting
Sponsor: Mirati Therapeutics Inc.
Advanced Cancer · Metastatic Cancer · Malignant Neoplasm of Lung
United States, Brazil, Croatia, France, Greece +13 more
Sponsor: EMD Serono Research & Development Institute, Inc.
Systemic Lupus Erythematosus (SLE) · Cutaneous Lupus Erythematosus (CLE)
United States, Japan, Switzerland
Sponsor: Pfizer
Melanoma · Glioma · Thyroid Cancer · Non-Small Cell Lung Cancer
United States, Australia, Brazil, Canada, China +2 more
Sponsor: AbbVie
Metastatic Pancreatic Ductal Adenocarcinoma · PDAC
United States, Australia, Israel, Italy, Japan +3 more
Sponsor: Merck Sharp & Dohme LLC
Non-small Cell Lung Cancer (NSCLC)
United States, Australia, Brazil, Canada, Chile +20 more
- A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's DiseaseActive Not Recruiting
Sponsor: AbbVie
Crohn's Disease
United States, Argentina, Australia, Austria, Belarus +42 more
- A Study to Test the Safety and Tolerability of Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged SeizuresEnrolling By Invitation
Sponsor: UCB Biopharma SRL
Stereotypical Prolonged Seizures
United States, Australia, Bulgaria, China, Czechia +7 more
Sponsor: AstraZeneca
Non-squamous Non-small Cell Lung Cancer
United States, Argentina, Australia, Belgium, Brazil +20 more
Sponsor: Amgen
Obstructive Sleep Apnea
United States, Australia, Brazil, Canada, Czechia +6 more
Sponsor: Merck Sharp & Dohme LLC
Coronavirus Disease (COVID-19)
United States, Argentina, Brazil, Bulgaria, Colombia +19 more
Sponsor: Hoffmann-La Roche
Obesity or Overweight · Type 2 Diabetes Mellitus
United States, Argentina, Australia, Brazil, Canada +15 more
Sponsor: AbbVie
Non Small Cell Lung Carcinoma
United States, Australia, Belgium, China, France +10 more
- A Phase 2 Bridging Study of Elacestrant Monotherapy in Advanced or Metastatic Breast CancerRecruiting
Sponsor: Stemline Therapeutics, Inc.
ER+/HER2- Advanced or Metastatic Breast Cancer
Japan
Sponsor: Pfizer
Metastatic Castration Sensitive Prostate Cancer (mCSPC) · Hormone Sensitive Prostate Cancer · Prostate Cancer · Cancer of the Prostate
United States, Argentina, Australia, Belgium, Brazil +21 more
Sponsor: EMD Serono Research & Development Institute, Inc.
Metastatic Colorectal Cancer
United States, Australia, Canada, China, Japan +2 more
Sponsor: Sanofi
Multiple Sclerosis
United States, Belgium, China, Italy, Japan
Sponsor: Merck Sharp & Dohme LLC
Breast Neoplasms
United States, Argentina, Australia, Brazil, Canada +21 more
Sponsor: Bristol-Myers Squibb
Extensive-Stage Small Cell Lung Cancer
United States, Argentina, Australia, Austria, Belgium +21 more
Sponsor: AbbVie
Rheumatoid Arthritis
United States, Argentina, Belgium, Brazil, Bulgaria +20 more
Sponsor: Astellas Pharma Global Development, Inc.
Advanced Solid Tumors
United States, China, France, Japan, Puerto Rico +1 more
Sponsor: Merck Sharp & Dohme LLC
Early Alzheimer's Disease
United States, Argentina, Australia, Belgium, Canada +6 more
- A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and OlderRecruiting
Sponsor: Pfizer
Clostridoides Difficile Associated Disease
United States, Argentina, Japan, United Kingdom